Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets ILS 1590.24 ILS 53.05 ILS 4774.77
  • Free AirMail shipping
60 tablets ILS 848.00 ILS 56.59 ILS 3395.34
  • Free AirMail shipping
30 tablets ILS 317.98 ILS 60.12 ILS 1803.69
  • Free AirMail shipping
20 tablets ILS 141.30 ILS 63.66 ILS 1273.14
  • Free AirMail shipping
10 tablets ILS 70.72 ILS 707.22
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets ILS 635.25 ILS 63.66 ILS 5729.76
  • Free AirMail shipping
60 tablets ILS 317.45 ILS 65.43 ILS 3925.89
  • Free AirMail shipping
30 tablets ILS 105.76 ILS 67.20 ILS 2015.91
  • Free AirMail shipping
20 tablets ILS 35.19 ILS 68.96 ILS 1379.25
  • Free AirMail shipping
10 tablets ILS 70.72 ILS 707.22
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets ILS 794.41 ILS 76.04 ILS 6843.92
  • Free AirMail shipping
60 tablets ILS 423.56 ILS 77.81 ILS 4668.66
  • Free AirMail shipping
30 tablets ILS 158.81 ILS 79.58 ILS 2387.30
  • Free AirMail shipping
20 tablets ILS 70.56 ILS 81.34 ILS 1626.84
  • Free AirMail shipping
10 tablets ILS 84.87 ILS 848.70
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.